Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Biological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Variability in Response to Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy

View source ↗

Summary

This clinical trial update describes a biological sample collection study to explore genetic and clinical-biological factors that influence variability in respo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mavacamten (mavacamten)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM) | Status: NOT_YET_RECRUITING